Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 1.000 | |
4fod | 0UV | ALK tyrosine kinase receptor | 2.7.10.1 | 0.604 | |
4foc | 0UU | ALK tyrosine kinase receptor | 2.7.10.1 | 0.568 | |
4cd0 | AWJ | ALK tyrosine kinase receptor | 2.7.10.1 | 0.548 | |
2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.540 | |
2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.525 | |
5aac | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.523 | |
2xa4 | AZ5 | Tyrosine-protein kinase JAK2 | / | 0.520 | |
5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.520 | |
4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.518 | |
3hrf | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.517 | |
4a06 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.517 | |
2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.513 | |
4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.513 | |
2xb7 | GUI | ALK tyrosine kinase receptor | 2.7.10.1 | 0.510 | |
4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.507 | |
5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.505 | |
2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.498 | |
4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.498 | |
4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.496 | |
5ack | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.496 | |
2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.495 | |
3t8o | ATP | Rhodopsin kinase | / | 0.495 | |
4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.495 | |
4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.493 | |
4b99 | R4L | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.491 | |
4ccb | OFG | ALK tyrosine kinase receptor | 2.7.10.1 | 0.491 | |
4rqk | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.491 | |
1byg | STU | Tyrosine-protein kinase CSK | / | 0.490 | |
2bfy | H1N | Aurora kinase B-A | 2.7.11.1 | 0.490 | |
3pxk | PXK | Focal adhesion kinase 1 | 2.7.10.2 | 0.489 | |
4y93 | 746 | Tyrosine-protein kinase | / | 0.489 | |
4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.488 | |
3a7h | ATP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.487 | |
4fnz | NZF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.487 | |
3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.486 | |
4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.486 | |
2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.485 | |
2ijm | ATP | Focal adhesion kinase 1 | 2.7.10.2 | 0.484 | |
5aab | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.484 | |
2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.483 | |
4rrv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.483 | |
3cd3 | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.482 | |
2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.481 | |
3sc1 | 3S1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.481 | |
2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.480 | |
2vgo | AD5 | Aurora kinase B-A | 2.7.11.1 | 0.479 | |
3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.479 | |
3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.478 | |
2yir | YIR | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.477 | |
4aoj | V4Z | High affinity nerve growth factor receptor | 2.7.10.1 | 0.476 | |
4rqv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.476 | |
3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.475 | |
4c62 | XWW | Tyrosine-protein kinase JAK2 | / | 0.475 | |
3hrc | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.474 | |
4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.474 | |
4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.474 | |
2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.473 | |
2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.473 | |
3v5l | 0G1 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.473 | |
4ft7 | H3K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.473 | |
2biy | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.472 | |
4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.472 | |
2xch | CKG | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.471 | |
3a62 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.471 | |
3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.471 | |
3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.471 | |
4ct2 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.471 | |
4g1w | G1W | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.471 | |
4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.471 | |
4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.471 | |
1yi3 | LY2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.470 | |
2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.470 | |
2ycq | UPX | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.470 | |
4dfn | 0K1 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.470 | |
4fv1 | EK4 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.470 | |
4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.470 | |
2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.469 | |
3lct | ADP | ALK tyrosine kinase receptor | 2.7.10.1 | 0.469 | |
4dfl | 0K0 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.469 | |
4k18 | 1OB | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.469 | |
4qo9 | 627 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.469 | |
2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.468 | |
2p33 | J07 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.468 | |
3emg | 685 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.468 | |
4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.467 | |
1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.466 | |
2itu | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.466 | |
3r2b | 05B | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.466 | |
4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.466 | |
1aq1 | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.465 | |
3zh8 | C58 | Protein kinase C iota type | 2.7.11.13 | 0.465 | |
4jrv | KJV | Epidermal growth factor receptor | 2.7.10.1 | 0.465 | |
5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.465 | |
3c4x | ATP | Rhodopsin kinase | / | 0.464 | |
3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.464 | |
4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.464 | |
1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.463 | |
2acx | ANP | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.463 | |
2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.463 | |
2o65 | MYF | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.463 | |
1pmn | 984 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.462 | |
2wtc | VGM | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.462 | |
3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.462 | |
4c34 | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.462 | |
4k1b | 1OC | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.462 | |
1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.461 | |
4j99 | ACP | Fibroblast growth factor receptor 2 | / | 0.461 | |
4wbo | ANW | Rhodopsin kinase | / | 0.461 | |
2brm | DFZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.460 | |
2pvn | P63 | Casein kinase II subunit alpha | 2.7.11.1 | 0.460 | |
2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.460 | |
4acc | 7YG | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.460 | |
4bfm | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.460 | |
4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.460 | |
3jxw | LXG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.459 | |
3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.459 | |
4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.459 | |
4jbo | WPH | Aurora kinase A | 2.7.11.1 | 0.459 | |
4mvf | STU | Calcium-dependent protein kinase 2 | 2.7.11.1 | 0.459 | |
2ydi | YDI | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.458 | |
4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.458 | |
4f65 | 0S9 | Fibroblast growth factor receptor 1 | / | 0.458 | |
4hvi | 19S | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.458 | |
1u54 | ACP | Activated CDC42 kinase 1 | / | 0.457 | |
2cdz | 23D | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.457 | |
2r7b | 253 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.457 | |
3bkb | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.457 | |
3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.457 | |
3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.457 | |
4dit | 0KD | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.457 | |
4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.457 | |
4qmt | H1N | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.457 | |
5e8y | STU | TGF-beta receptor type-2 | 2.7.11.30 | 0.457 | |
2br1 | PFP | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.456 | |
2x1n | X1N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
3le6 | 2BZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.455 | |
2j0k | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.455 | |
2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.455 | |
3rwp | ABQ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.455 | |
4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.455 | |
4bl1 | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.455 | |
4d0l | 093 | Phosphatidylinositol 4-kinase beta | 2.7.1.67 | 0.455 | |
4dta | ADN | APH(2'')-Id | / | 0.455 | |
4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.455 | |
1nvr | STU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.454 | |
2buj | STU | Serine/threonine-protein kinase 16 | / | 0.454 | |
2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 | 0.454 | |
3et7 | 349 | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.454 | |
3k5u | PFQ | Aurora kinase A | 2.7.11.1 | 0.454 | |
4l9i | 8PR | Rhodopsin kinase | / | 0.454 | |
4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.454 | |
4y95 | 746 | Tyrosine-protein kinase | / | 0.454 | |
4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.454 | |
2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.453 | |
2itp | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.453 | |
2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.453 | |
2wmu | ZYU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.453 | |
4c57 | FEF | Cyclin-G-associated kinase | 2.7.11.1 | 0.453 | |
4e73 | 0NR | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.453 | |
4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.453 | |
1oky | STU | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.452 | |
4ct1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.452 | |
4yhj | AN2 | G protein-coupled receptor kinase 4 | 2.7.11.16 | 0.452 | |
3d7t | STU | Tyrosine-protein kinase CSK | / | 0.451 | |
3we4 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.451 | |
4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.451 | |
2w7x | D1A | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.450 | |
4cki | ADN | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.450 | |
4e93 | GUI | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.450 | |
4enx | Z20 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.450 | |
4erw | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.449 | |
4jqe | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.449 | |
5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.449 | |
1uu3 | LY4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.448 | |
2cgx | 3D3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.448 | |
2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.448 | |
3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.448 | |
3js2 | VM1 | Fibroblast growth factor receptor 1 | / | 0.448 | |
3rvg | 17P | Tyrosine-protein kinase JAK2 | / | 0.448 | |
3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.448 | |
1nvq | UCN | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
1pkd | UCN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
2brh | DFW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
2wxv | WXV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
2zoq | 5ID | Mitogen-activated protein kinase 3 | 2.7.11.24 | 0.447 | |
3f5p | 741 | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.447 | |
3ncg | BK1 | Calmodulin-domain protein kinase 1, putative | / | 0.447 | |
3orm | AGS | Serine/threonine protein kinase | / | 0.447 | |
3s2a | 2NQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.447 | |
3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.447 | |
4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.447 | |
1u59 | STU | Tyrosine-protein kinase ZAP-70 | 2.7.10.2 | 0.446 | |
2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.446 | |
3c7q | XIN | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.446 | |
3du8 | 553 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.446 | |
3l1s | Z92 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.446 | |
3qcs | 3Q1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.446 | |
4ach | KDI | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.446 | |
4ccu | AWF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.446 | |
4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.446 | |
4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.446 | |
5dr6 | SKE | Aurora kinase A | 2.7.11.1 | 0.446 | |
2obj | VRV | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.445 | |
3she | I85 | MAP kinase-activated protein kinase 3 | 2.7.11.1 | 0.445 | |
4eny | J19 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.445 | |
4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.445 | |
4gfg | 0XF | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.445 | |
1okz | UCN | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.444 | |
1uvr | BI8 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.444 | |
2clq | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.444 | |
2vz6 | FEF | Calcium/calmodulin-dependent protein kinase type II subunit alpha | 2.7.11.17 | 0.444 | |
2xyu | Q9G | Ephrin type-A receptor 4 | 2.7.10.1 | 0.444 | |
2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
2yn8 | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.444 | |
3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.444 | |
3nun | JMZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.444 | |
3zmm | F9J | Tyrosine-protein kinase JAK2 | / | 0.444 | |
2brg | DFY | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
2ijm | ADP | Focal adhesion kinase 1 | 2.7.10.2 | 0.443 | |
2wih | P48 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.443 | |
3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.443 | |
4jq7 | KJQ | Epidermal growth factor receptor | 2.7.10.1 | 0.443 | |
1h1s | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
1q41 | IXM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.442 | |
1uu8 | BI1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.442 | |
2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.442 | |
2ydj | YDJ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
3cgo | JNO | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.442 | |
3qyw | 6PB | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.442 | |
3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.442 | |
4acd | GR9 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.442 | |
4b7s | QLE | Cytochrome P450 monooxygenase PikC | / | 0.442 | |
4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.442 | |
4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.442 | |
4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.442 | |
4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.442 | |
1rw8 | 580 | TGF-beta receptor type-1 | 2.7.11.30 | 0.441 | |
2e9n | 76A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.441 | |
3oro | AGS | Serine/threonine protein kinase | / | 0.441 | |
3umx | Q18 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.441 | |
4agu | D15 | Cyclin-dependent kinase-like 1 | / | 0.441 | |
4enh | FVX | Cholesterol 24-hydroxylase | / | 0.441 | |
1eh4 | IC1 | Casein kinase I homolog 1 | 2.7.11.1 | 0.440 | |
2itw | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.440 | |
2xm9 | LWH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.440 | |
2ym4 | 4YM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
3bqr | 4RB | Death-associated protein kinase 3 | / | 0.440 | |
4bbe | 3O4 | Tyrosine-protein kinase JAK2 | / | 0.440 | |
4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
4iwo | 1H4 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.440 | |
4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.440 |